Search references for EVACETRAPIB. Phrases containing EVACETRAPIB
See searches and references containing EVACETRAPIB!EVACETRAPIB
Chemical compound
Evacetrapib was a drug under development by Eli Lilly and Company (investigational name LY2484595) that inhibits cholesterylester transfer protein (CETP
Evacetrapib
Drug class
meaningful clinical improvement despite HDL increases (dalcetrapib, evacetrapib). Failed: Torcetrapib: failed in 2006 due to excess deaths in Phase III
CETP_inhibitor
eupatilin (INN) euprocin (INN) Eurax Eurneffy Euthroid Eutonyl Eutron evacetrapib (INN) Evalose evatanepag (USAN, INN) Evdi Evenity everolimus (USAN) Evfraxy
List_of_drugs:_Eu–Ez
Mammalian protein found in Homo sapiens
2017, its development was abandoned by Merck. The other was Eli Lilly's evacetrapib, which failed in Phase 3 trials. Click on genes, proteins and metabolites
Cholesteryl ester transfer protein
Cholesteryl_ester_transfer_protein
Chemical compound
and did raise HDL, but it showed no clinically meaningful efficacy. Evacetrapib was developed by Eli Lilly and Company until October 2015. Gutstein DE
Anacetrapib
travel, tourism, insurance
EVACETRAPIB
EVACETRAPIB
EVACETRAPIB
EVACETRAPIB
EVACETRAPIB
EVACETRAPIB
EVACETRAPIB
EVACETRAPIB
EVACETRAPIB
travel, tourism, insurance